Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine

BACKGROUND: Effects of galcanezumab, a monoclonal antibody against calcitonin gene-related peptide, on patient satisfaction, health care resource utilization (HCRU), and acute medication use were evaluated in a long-term, open-label study in patients with migraine. METHODS: Patients with episodic (7...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, Janet H, Foster, Shonda A, Stauffer, Virginia L, Ruff, Dustin D, Aurora, Sheena K, Versijpt, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239121/
https://www.ncbi.nlm.nih.gov/pubmed/30519007
http://dx.doi.org/10.2147/PPA.S182563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239121/
https://www.ncbi.nlm.nih.gov/pubmed/30519007
http://dx.doi.org/10.2147/PPA.S182563

Ejemplares similares